Skip to main content

Phase 4 Trials

Meaning

Phase 4 Trials, also clinically known as post-marketing surveillance trials, represent the final, long-term stage of the clinical research process, occurring only after a new drug or intervention has been approved by regulatory bodies and released to the general market. The primary objective is to monitor the intervention’s long-term safety profile, its efficacy in diverse, real-world patient populations, and to identify any rare or delayed adverse effects that were not evident in earlier, smaller-scale trials. This stage is crucial for collecting comprehensive safety data and optimizing the dosage or usage protocols in a broad clinical setting. It ensures continuous refinement of therapeutic knowledge.